Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Pfizer-Allergan merger

‘Over 90%’ of industry thinks Pfizer will sell generics biz

Pfizer says it will decide in 2018 whether to split its generics and branded businesses but M&A experts are already predicting how the giant will get rid of its established drugs programme.

Oramed inks China licensing deal for oral insulin candidate

Hefei will manufacture the API for Oramed's oral insulin tablet as part of a potential $50m licensing deal in China, Hong Kong and Macau.

ManKind plans to build manufacturing plant in the Himalayas

ManKind Pharma plans to set up manufacturing facilities in Northeast India to bring production in-house and cut its tax bill.


The latest pharma appointments's round-ups of the industry's latest clinical and executive hires.

Happy Thefts-giving: Drugmakers need to be extra vigilant during the holidays says expert

The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.

Teva tackles migraine through potential $400m Heptares collaboration

Teva has teamed with Heptares to develop and commercialise easily-deliverable small-molecule calcitonin gene-related peptide (GPCR) antagonists to treat migraine.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...